 |
This page has not been fully approved by the PsychonautWiki administrators. It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards. |
| Summary sheet: DMXE |
| DMXE | |||||
|---|---|---|---|---|---|
 |
|||||
| Chemical Nomenclature | |||||
| Common names | DMXE | ||||
| Substitutive name | Deoxymethoxetamine | ||||
| Systematic name | 2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one | ||||
| Class Membership | |||||
| Psychoactive class | Dissociative / Hallucinogen | ||||
| Chemical class | Arylcyclohexylamine | ||||
| Routes of Administration | |||||
|
|||||
| Interactions | |||||
Deoxymethoxetamine (also known as DMXE) is a dissociative substance of the arylcyclohexylamine class that produces ketamine-like dissociative effects when administered.
DMXE has been sold online since around October 2022, marketed as a legal replacement for MXE. [1]
Limited data exists about the pharmacological properties, metabolism, and toxicity of DMXE in humans, and it has a limited history of human use. It is highly advised to use harm reduction practices if using this substance.
History and culture
 |
This History and culture section is a stub. As a result, it may contain incomplete or wrong information. You can help by expanding it. |
Chemistry
 |
This chemistry section is incomplete. You can help by adding to it. |
DMXE, like the majority of dissociatives, belongs to the class of arylcyclohexylamines. It is derived from MXE, having the methoxy residue replaced with a methyl residue [2]. DMXE's molecular formula therefore lacks an oxygen, which results in more hydrophobic and less bulky structure - causing the slight differences in pharmacology.
Pharmacology
 |
This pharmacology section is incomplete. You can help by adding to it. |
DMXE acts as an NMDA receptor antagonist. A specific subtype of glutamate receptor, NMDA (N-Methyl-D-Aspartate), modulates the transmission of electrical signals between neurons in the brain and spinal cord; for the signals to pass, the receptor must be open.
Dissociatives inhibit the normal functioning NMDA receptors by binding to and blocking them. This disruption of neural network activity leads to loss of normal cognitive and affective processing, psychomotor functioning, anesthesia and eventually the equivalent of a "k-hole".
An in silico study showed that DMXE binds to the same site of NMDARs as MXE and posseses comparable potency [2]
Subjective effects
 |
This subjective effects section is a stub. As such, it is still in progress and may contain incomplete or wrong information. You can help by expanding or correcting it. |
Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.
It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.
Physical effects 
-
- Stimulation and Sedation - DMXE has been compared to MXE which is known for its especially sedating and relaxing effects. However dissociatives are also able to induce stimulation, usually in lower doses.
- Pain relief
- Motor control loss
- Tactile suppression
- Physical euphoria
Disconnective effects 
-
- Tactile disconnection
- Visual disconnection - This eventually results in DMXE's equivalent of the "k-hole" or more specifically, holes, spaces and voids alongside of structures.
Visual effects 
-
Suppression
Distortions
Geometry
If applicable, a brief paragraph summary describing the visual geometry produced by the substance may be included here.
Hallucinatory states
If applicable, a brief summary of the substance's visual effects profile may be written here.
Experience reports
There are currently 0 experience reports which describe the effects of this substance in our experience index.
Additional experience reports can be found here:
Toxicity and harm potential
The toxicity and long-term health effects of recreational DMXE use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown.
This is because DMXE is a research chemical with a very brief history of human usage.
It is strongly recommended that one use harm reduction practices when using this substance.
Lethal dosage
Tolerance and addiction potential
Dangerous interactions
 |
This dangerous interactions section is a stub. As such, it may contain incomplete or invalid information. You can help by expanding upon or correcting it. |
Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).
Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.
Legal status
 |
This legality section is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
See also
External links
(List along order below)
Literature
- APA formatted reference
Please see the citation formatting guide if you need assistance properly formatting citations.
References
- ↑ Alert from NDEWS Web Monitoring team: Increases in Reddit discussions of DMXE, October 2020–March 2021 | https://ndews.org/?wysija-page=1&controller=email&action=view&email_id=125&wysijap=subscriptions
- ↑ 2.0 2.1 Irie, T., Yanase, Y., Demizu, Y., Usami, M., & Kikura-Hanajiri, R. (2022). Derivatives of methoxetamine and major methoxetamine metabolites potently block NMDA receptors. In Journal of Pharmacological Sciences (Vol. 150, Issue 4, pp. 233–243). Elsevier BV. [1]